G

GH Research PLC
NASDAQ:GHRS

Watchlist Manager
GH Research PLC
NASDAQ:GHRS
Watchlist
Price: 8.75 USD -5.3% Market Closed
Market Cap: 455.3m USD
Have any thoughts about
GH Research PLC?
Write Note

GH Research PLC
Cash & Cash Equivalents

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

GH Research PLC
Cash & Cash Equivalents Peer Comparison

Comparables:
PRGO
JAZZ
AVDL
COPN
OVB

Competitive Cash & Cash Equivalents Analysis
Latest Figures & CAGR of Competitors

Company Cash & Cash Equivalents CAGR 3Y CAGR 5Y CAGR 10Y
G
GH Research PLC
NASDAQ:GHRS
Cash & Cash Equivalents
$78.4m
CAGR 3-Years
137%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Perrigo Company PLC
NYSE:PRGO
Cash & Cash Equivalents
$1.5B
CAGR 3-Years
-11%
CAGR 5-Years
30%
CAGR 10-Years
5%
Jazz Pharmaceuticals PLC
NASDAQ:JAZZ
Cash & Cash Equivalents
$2.2B
CAGR 3-Years
60%
CAGR 5-Years
50%
CAGR 10-Years
N/A
Avadel Pharmaceuticals PLC
NASDAQ:AVDL
Cash & Cash Equivalents
$28.8m
CAGR 3-Years
-25%
CAGR 5-Years
11%
CAGR 10-Years
-6%
Cosmo Pharmaceuticals NV
SIX:COPN
Cash & Cash Equivalents
€54.6m
CAGR 3-Years
-33%
CAGR 5-Years
-19%
CAGR 10-Years
7%
Ovoca Bio PLC
LSE:OVB
Cash & Cash Equivalents
€2.9m
CAGR 3-Years
-32%
CAGR 5-Years
2%
CAGR 10-Years
-11%

See Also

What is GH Research PLC's Cash & Cash Equivalents?
Cash & Cash Equivalents
78.4m USD

Based on the financial report for Dec 31, 2023, GH Research PLC's Cash & Cash Equivalents amounts to 78.4m USD.

What is GH Research PLC's Cash & Cash Equivalents growth rate?
Cash & Cash Equivalents CAGR 3Y
137%

Over the last year, the Cash & Cash Equivalents growth was -53%. The average annual Cash & Cash Equivalents growth rates for GH Research PLC have been 137% over the past three years .

Back to Top